4,389 Shares in Waters Corporation $WAT Purchased by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd purchased a new stake in Waters Corporation (NYSE:WAT) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 4,389 shares of the medical instruments supplier’s stock, valued at approximately $1,316,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in WAT. Root Financial Partners LLC purchased a new stake in Waters during the third quarter worth $26,000. IFP Advisors Inc raised its position in shares of Waters by 65.4% in the second quarter. IFP Advisors Inc now owns 134 shares of the medical instruments supplier’s stock worth $51,000 after acquiring an additional 53 shares during the period. CYBER HORNET ETFs LLC purchased a new stake in shares of Waters during the 2nd quarter worth about $53,000. Versant Capital Management Inc grew its position in shares of Waters by 510.3% during the 3rd quarter. Versant Capital Management Inc now owns 177 shares of the medical instruments supplier’s stock valued at $53,000 after acquiring an additional 148 shares during the period. Finally, Quent Capital LLC purchased a new position in shares of Waters in the 3rd quarter valued at about $59,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Down 1.3%

Shares of NYSE WAT opened at $370.47 on Friday. The stock has a market cap of $22.06 billion, a PE ratio of 34.05, a P/E/G ratio of 3.14 and a beta of 1.16. The company has a current ratio of 1.53, a quick ratio of 1.08 and a debt-to-equity ratio of 0.41. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $423.00. The company has a 50-day moving average of $390.42 and a 200 day moving average of $343.38.

Waters (NYSE:WAT) last released its earnings results on Tuesday, November 4th. The medical instruments supplier reported $3.40 earnings per share for the quarter, topping analysts’ consensus estimates of $3.21 by $0.19. The business had revenue of $799.89 million for the quarter, compared to analyst estimates of $780.05 million. Waters had a net margin of 20.89% and a return on equity of 36.59%. The business’s revenue was up 8.1% on a year-over-year basis. During the same period last year, the company posted $2.93 EPS. Waters has set its FY 2025 guidance at 13.050-13.150 EPS and its Q4 2025 guidance at 4.450-4.550 EPS. As a group, sell-side analysts predict that Waters Corporation will post 12.86 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have issued reports on WAT. Wolfe Research upgraded Waters from a “peer perform” rating to an “outperform” rating and set a $480.00 price target on the stock in a research report on Wednesday, December 10th. TD Cowen reissued a “hold” rating on shares of Waters in a research note on Wednesday, November 5th. JPMorgan Chase & Co. boosted their price target on shares of Waters from $300.00 to $325.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. Rothschild & Co Redburn assumed coverage on shares of Waters in a report on Wednesday, October 8th. They set a “buy” rating and a $390.00 price objective on the stock. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Waters in a research note on Wednesday, January 21st. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $398.61.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.